A Phase II Trial of AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs AZD-1775 (Primary) ; Carboplatin; Paclitaxel
- Indications Lung cancer; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 06 Jun 2017 Results of interim analysis (n=15), presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 15 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 19 Aug 2015 Planned initiation date changed from 1 Aug 2015 to 1 Oct 2015 as reported by ClinicalTrials.gov record.